[1]
“Drug repurposing of Daclatasvir and Famciclovir as antivirals against dengue virus infection by in silico and in vitro techniques”, IJBB, vol. 58, no. 6, pp. 557–564, Jun. 2023, doi: 10.56042/ijbb.v58i6.57794.